Johnson & Johnson Reports Q2 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
'Sunshine and Blue Skies' Ahead For Johnson & Johnson (JNJ) Following Strong Q2 Beat
July 21, 2021 9:53 AM EDTEarlier today, Johnson & Johnson (NYSE: JNJ) reported a strong Q2 beat both on the top and bottom lines: EPS of $2.48, $0.22 better than the analyst estimates of $2.26, and revenues of $23.31B versus the consensus estimate of $22.19B.
The company also revised its full-year guidance to the upside: FY2021 EPS of $9.60-$9.70, vs consensus of... More
Johnson & Johnson (JNJ) Tops Q2 EPS by 22c, Updates FY Guidance
July 21, 2021 6:28 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.48, $0.22 better than the analyst estimate of $2.26. Revenue for the quarter came in at $23.31 billion versus the consensus estimate of $22.19 billion.
GUIDANCE:
Johnson & Johnson sees FY2021 EPS of $9.60-$9.70, versus the consensus of $9.52.... More
